FDA Inspection 987875 — UF Reproductive Medicine at Springhill

UF Reproductive Medicine at Springhill — FEI 3003926999

The FDA completed an inspection of UF Reproductive Medicine at Springhill on September 27, 2016 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Gainesville, FL (United States)